Concerns about GLP-1 drugs indicated for weight loss were first raised after the FDA's Adverse Event Reporting System ...

The U.S. health regulator asked drugmakers on Tuesday to remove warnings about a potential risk of suicidal thoughts from ...

The FDA is requesting that manufacturers of three GLP-1 receptor agonists remove information on risk for suicidal ideation ...

The US Food and Drug Administration found no increased risk of suicidal behavior or ideation linked to popular weight-loss ...

The request comes after a two-year review into reported links between GLP-1RAs and psychiatric adverse events.

Meanwhile, the FDA has asked manufacturers of flu vaccines to update their labels to include warnings about the risk of ...

The FDA is weighing a change that could make warning labels on dietary supplements appear less often on packaging.

The U.S. health regulator asked drugmakers on Tuesday to remove warnings about a potential ​risk of suicidal thoughts from widely used GLP-1 weight-loss drugs, including Novo Nordisk's Wegovy and Eli ...

Hormone therapy helps women. Now the FDA is reversing its warning on estrogen treatment which could change treatemtn for ...

Miach Orthopaedics' BEAR Implant label updated to include significantly lower risk of post-traumatic osteoarthritis following ...

The U.S. Food and Drug Administration announced it will now be requiring updated safety labels for all opioid pain medications to better highlight the risks of long-term use, including misuse, ...